Sun Pharma Advanced Research Company Limited (SPARC.NS)
INR 145.48
(1.29%)
INR 145.48
(1.29%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.07 Billion INR | 5.0% |
| 2022 | 2.93 Billion INR | 41.82% |
| 2021 | 2.06 Billion INR | 7.36% |
| 2020 | 1.92 Billion INR | -3.07% |
| 2019 | 1.98 Billion INR | 13.74% |
| 2018 | 1.74 Billion INR | -5.57% |
| 2017 | 1.84 Billion INR | 30.91% |
| 2016 | 1.41 Billion INR | 51.82% |
| 2015 | 930.16 Million INR | 20.86% |
| 2014 | 769.59 Million INR | -40.25% |
| 2013 | 1.28 Billion INR | 31.89% |
| 2012 | 976.59 Million INR | 3.19% |
| 2011 | 946.38 Million INR | 60.3% |
| 2010 | 590.37 Million INR | 20.88% |
| 2009 | 488.37 Million INR | 28.48% |
| 2008 | 380.12 Million INR | 7.91% |
| 2007 | 352.27 Million INR | 2205.01% |
| 2006 | 15.28 Million INR | 0.0% |
| 2005 | - INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 513.79 Million INR | -20.83% |
| 2024 Q2 | 689.8 Million INR | -140.83% |
| 2023 Q4 | 649 Million INR | -25.32% |
| 2023 Q3 | 869 Million INR | -4.66% |
| 2023 Q2 | 911.5 Million INR | 4.67% |
| 2023 Q1 | 870.8 Million INR | 14.38% |
| 2023 FY | 3.07 Billion INR | 5.0% |
| 2022 Q3 | 821.8 Million INR | 27.89% |
| 2022 Q1 | 705.9 Million INR | 31.74% |
| 2022 FY | 2.93 Billion INR | 41.82% |
| 2022 Q4 | 761.3 Million INR | -7.36% |
| 2022 Q2 | 642.6 Million INR | -8.97% |
| 2021 Q2 | 546.1 Million INR | 6.62% |
| 2021 Q4 | 535.84 Million INR | 6.89% |
| 2021 Q1 | 512.2 Million INR | 11.94% |
| 2021 Q3 | 501.3 Million INR | -8.2% |
| 2021 FY | 2.06 Billion INR | 7.36% |
| 2020 Q2 | 418.2 Million INR | -28.29% |
| 2020 Q3 | 465.6 Million INR | 11.33% |
| 2020 FY | 1.92 Billion INR | -3.07% |
| 2020 Q4 | 457.56 Million INR | -1.73% |
| 2020 Q1 | 583.2 Million INR | 21.94% |
| 2019 Q4 | 478.25 Million INR | 7.81% |
| 2019 Q3 | 443.6 Million INR | -3.73% |
| 2019 FY | 1.98 Billion INR | 13.74% |
| 2019 Q1 | 602.8 Million INR | 74.27% |
| 2019 Q2 | 460.8 Million INR | -23.56% |
| 2018 FY | 1.74 Billion INR | -5.57% |
| 2018 Q1 | 489.6 Million INR | -3.22% |
| 2018 Q3 | 472 Million INR | 7.69% |
| 2018 Q4 | 345.89 Million INR | -26.72% |
| 2018 Q2 | 438.3 Million INR | -10.48% |
| 2017 Q4 | 505.9 Million INR | 39.33% |
| 2017 FY | 1.84 Billion INR | 30.91% |
| 2017 Q3 | 363.1 Million INR | -5.0% |
| 2017 Q2 | 382.2 Million INR | -5.49% |
| 2017 Q1 | 404.4 Million INR | 7.38% |
| 2016 Q1 | 321.9 Million INR | 30.85% |
| 2016 FY | 1.41 Billion INR | 51.82% |
| 2016 Q4 | 376.6 Million INR | 0.91% |
| 2016 Q3 | 373.2 Million INR | 6.96% |
| 2016 Q2 | 348.9 Million INR | 8.39% |
| 2015 Q3 | 214.5 Million INR | -21.14% |
| 2015 Q4 | 246 Million INR | 14.69% |
| 2015 FY | 930.16 Million INR | 20.86% |
| 2015 Q1 | 207.4 Million INR | -2.49% |
| 2015 Q2 | 272 Million INR | 31.15% |
| 2014 Q3 | 190.1 Million INR | -2.36% |
| 2014 Q1 | 178.8 Million INR | -77.97% |
| 2014 Q4 | 212.69 Million INR | 11.89% |
| 2014 FY | 769.59 Million INR | -40.25% |
| 2014 Q2 | 194.7 Million INR | 8.89% |
| 2013 Q3 | 156.8 Million INR | -4.1% |
| 2013 Q1 | 156.2 Million INR | -72.08% |
| 2013 FY | 1.28 Billion INR | 31.89% |
| 2013 Q4 | 811.55 Million INR | 417.57% |
| 2013 Q2 | 163.5 Million INR | 4.67% |
| 2012 Q2 | 134.4 Million INR | -6.21% |
| 2012 Q1 | 143.3 Million INR | -75.75% |
| 2012 FY | 976.59 Million INR | 3.19% |
| 2012 Q4 | 559.39 Million INR | 296.45% |
| 2012 Q3 | 141.1 Million INR | 4.99% |
| 2011 FY | 946.38 Million INR | 60.3% |
| 2011 Q4 | 590.98 Million INR | 382.83% |
| 2011 Q3 | 122.4 Million INR | 0.0% |
| 2010 FY | 590.37 Million INR | 20.88% |
| 2009 FY | 488.37 Million INR | 28.48% |
| 2008 FY | 380.12 Million INR | 7.91% |
| 2007 FY | 352.27 Million INR | 2205.01% |
| 2006 FY | 15.28 Million INR | 0.0% |
| 2005 FY | - INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 80.612% |
| Hester Biosciences Limited | 908.84 Million INR | -238.541% |
| Aarti Drugs Limited | 1.16 Billion INR | -163.542% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -0.078% |
| Albert David Limited | 1.02 Billion INR | -199.84% |
| Alembic Limited | 872.45 Million INR | -252.659% |
| Alkem Laboratories Limited | 32.83 Billion INR | 90.63% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -575.351% |
| Bajaj HealthCare Limited | 985.34 Million INR | -212.256% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -45014.37% |
| Brooks Laboratories Limited | 51.18 Million INR | -5911.723% |
| Eris Lifesciences Limited | 4.94 Billion INR | 37.754% |
| FDC Limited | 3.49 Billion INR | 12.085% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | 73.569% |
| Gufic Biosciences Limited | 1.18 Billion INR | -159.298% |
| Hikal Limited | 4.46 Billion INR | 31.072% |
| Ind-Swift Limited | 946.56 Million INR | -225.048% |
| Innova Captab Limited | 931.03 Million INR | -230.473% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -39.791% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -601.585% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 78.713% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -186.431% |
| Lupin Limited | 125.09 Billion INR | 97.54% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -1796.59% |
| Medico Remedies Limited | 59.67 Million INR | -5055.928% |
| Morepen Laboratories Limited | 1.98 Billion INR | -54.811% |
| Nectar Lifesciences Limited | 932.7 Million INR | -229.881% |
| Orchid Pharma Limited | 800.77 Million INR | -284.23% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -2.718% |
| RPG Life Sciences Limited | 1.63 Billion INR | -88.126% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -646.023% |
| Sigachi Industries Limited | 579.88 Million INR | -430.586% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -20.465% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -119.334% |
| Themis Medicare Limited | 1.12 Billion INR | -173.299% |
| Unichem Laboratories Limited | 6.72 Billion INR | 54.254% |
| Vaishali Pharma Limited | 84.02 Million INR | -3561.593% |
| Wanbury Limited | 978.96 Million INR | -214.291% |
| Windlas Biotech Limited | 1 Billion INR | -205.69% |
| ZIM Laboratories Limited | 1.01 Billion INR | -203.714% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -44.846% |
| Ipca Laboratories Limited | 18.98 Billion INR | 83.796% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 98.004% |
| Venus Remedies Limited | 1.91 Billion INR | -60.561% |
| Sakar Healthcare Limited | 204.07 Million INR | -1407.651% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 94.472% |
| Divi's Laboratories Limited | 14.17 Billion INR | 78.287% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -24.391% |
| Mankind Pharma Limited | 29.27 Billion INR | 89.489% |
| Sequent Scientific Limited | 2.9 Billion INR | -6.03% |
| Laurus Labs Limited | 11.9 Billion INR | 74.166% |
| Neuland Laboratories Limited | 2.92 Billion INR | -5.019% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 79.2% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 93.447% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 97.543% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -46.932% |
| Wockhardt Limited | 8.48 Billion INR | 63.717% |
| Bal Pharma Limited | 555.62 Million INR | -453.754% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 96.791% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -116.795% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -5178.615% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -41.495% |
| Shilpa Medicare Limited | 3.33 Billion INR | 7.719% |
| Valiant Laboratories Limited | 138.02 Million INR | -2129.097% |
| Ajanta Pharma Limited | 30.46 Billion INR | 89.9% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -21547.787% |
| Granules India Limited | 10.31 Billion INR | 70.165% |
| Medicamen Biotech Limited | 335.16 Million INR | -817.99% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -790.193% |
| Piramal Enterprises Limited | 63.65 Billion INR | 95.166% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 85.637% |
| NATCO Pharma Limited | 10.05 Billion INR | 69.409% |
| Suven Life Sciences Limited | 109.75 Million INR | -2703.462% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -6566.089% |
| Strides Pharma Science Limited | 9.16 Billion INR | 66.419% |
| Indoco Remedies Limited | 12.06 Billion INR | 74.49% |
| Alpa Laboratories Limited | 127.38 Million INR | -2315.45% |
| Lasa Supergenerics Limited | 291.17 Million INR | -956.688% |